Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis
Clinical trial NCT01482884 · COMPLETED
Trial details
- NCT number
- NCT01482884
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.